AzTrials
AzTrials

Stroke, IschemicBHSNCT03592563

CUHK Brain Health Longitudinal Study

An observational study of Stroke, Ischemic and Stroke Syndrome, run by Chinese University of Hong Kong at 2 sites in Hong Kong.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

The goal of this study is to develop a large longitudinal cohort of individuals diagnosed with or at high risk for brain diseases (both neurological and psychiatric in nature), in order to identify risk factors that contribute to neurological and psychiatric diseases over time. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stroke, Ischemic, Stroke Syndrome, Stroke
What is being tested?
Neuro-QoL questionnaire
How many people
5,000 participants
Where
2 sitesHong Kong
Study dates
1 Jul 2019to 31 Dec 2048
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: 1. Chinese ONLY 2. Hong Kong Resident

Who may be able to join

  • Adult ≥ 18 years of age
  • Fulfilling criteria for membership in one of these three groups:
  • Red group: established diagnosis of one or more neurological and/or psychiatric conditions
  • Yellow group: high-risk to develop one or more neurological and/or psychiatric conditions
  • family history (first degree relative) one or more neurological and/or psychiatric conditions
  • examination, imaging or laboratory findings consistent with pre-symptomatic stages of one or more neurological and/or psychiatric disorders
Show all 9Show fewer
  • Green group: not meeting criteria for Red or Yellow groups, but interested in longitudinal research on maintenance and/or improvement of brain health
  • Subject provides informed consent by signing and dating the written informed consent form
  • Subject is willing to answer health questionnaires and be followed longitudinally

Who cannot join

  • None

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Thomas Wai Hong LEUNG, FRCP contact

852-35053593

drtleung@cuhk.edu.hk

Tiffany Chung, M.Phil contact

852-35053856

tiffanyc@cuhk.edu.hk

Hong Kong2 sites, 2 recruiting
  • Chinese University of Hong Kong

    Hong Kong

    Thomas Wai Hong LEUNG, FRCP, 852-35053593, drtleung@cuhk.edu.hk

    Anki MIU, MSc, 852-28902002, ankimiu@cuhk.edu.hk

    Recruiting
  • The Chinese University of Hong Kong

    Hong Kong

    Thomas Wai Hong LEUNG, FRCP, 852-35053593, drtleung@cuhk.edu.hk

    Recruiting

Other trials in Hong Kong

About this study

The goal of this study is to develop a large longitudinal cohort of individuals diagnosed with or at high risk for brain diseases (both neurological and psychiatric in nature), in order to identify risk factors that contribute to neurological and psychiatric diseases over time. The investigators seek to capture relevant information from medical records, electronically administered questionnaires and follow up phone-based interviews. The investigators expect to eventually have sufficient power from our dataset to examine risk factors for a variety of brain disorders, both individually and in aggregate. Our ultimate goal is to offer scientifically validated ways to preserve and promote brain health by working with our patients' needs and tracking their progress over time.

Read the detailed description

For those interested participants, our services coordinator, co-investigator or principal investigator will interview and explain the study in detail and obtain your consent. After signed the consent, the participant should complete the Neuro-QoL (Quality of Life in Neurological Disorders) questionnaire first, either on-site at CUHK Brain Health Centre located at Tsim Sha Tsui in Hong Kong, PWH or community centre. The questions in the questionnaire focus on the following: ability to participate in social roles, emotional and behavioral dyscontrol, fatigue, lower extremity function, stigma, upper extremity function, positive affect and well-being, satisfaction with social roles, cognitive function, anxiety and depression. These questions enable us to get a full picture of the participant's health. Participants in Green and yellow groups will receive this standard battery of questions. However, participants in Red group may receive an additional subset of questions based on their clinical diagnosis. Once again, all subjects are asked to complete this questionnaire for clinical evaluation purposes, regardless of whether or not they decide to participate in this study.

When the participant is willing to join the study, an evaluation would be scheduled. At that visit, our physician and/or study coordinator will review the participant's medical history, current concerns, and responses to the questionnaires. Diagnostic and therapeutic recommendations may be offered, as warranted. The investigator or physician will determine whether a follow-up clinic visit is warranted. Depending on the physician's recommendations, the participant will either participate in a research phone call in approximately 6 months, or will be scheduled for in person research follow up. In addition to the phone call or clinic visit, and will also receive an identical questionnaire to the first one by e-mail, by phone, or in person. Follow-up over time will continue (either in-person or over the phone) using the same questionnaires at approximately 6-month intervals. During follow-up, participant will be screened for new signs, symptoms and diagnoses of neurological and/or psychiatric disorders, in order to correlate these outcomes with risk factors captured using the procedures described above.

The proposed study does not involve formulating new diagnoses or directly offering treatment for neurological and/or psychiatric conditions. All patients admitted to PWH or other medical institutes will be treated according to the standard care at the corresponding institution, regardless of their decision to participate in this repository. Should results from this study lead to discovery of one or more factors associated with development of brain disease, the principal investigators, co-investigators, or study coordinator in the CUHK Brain Health Centre will inform, counsel and offer diagnostic and/or therapeutic recommendations to participants accordingly. The participants may be referred to relevant departments for follow-up clinical visits and may also be invited to participate in sister research projects at PWH/CUHK that have obtained ethics approval; if the participants are interested in any sister projects, they may be offered tests as the study procedures of these projects, including but not limited to blood tests, genetic tests, retinal imaging and brain imaging exams.

Our study aims to follow longitudinally individuals with or at risk for neurological and psychiatric disease, regardless of gender or sexual orientation. The investigators focus on enrolling adults as the vast majority of the neurological and psychiatric conditions of interest are diagnosed well into adulthood; indeed, most are age-related and particularly frequent among individuals in the fifth decade of life and beyond. Our study uniquely welcomes even individuals who are healthy from a brain standpoint, and offers them an opportunity to increase our scientific understanding of the early transition from normal to pathological brain functioning. As a result, the entire population as a whole stand to potentially benefit from the outcomes of the proposed research.

Being tested
Neuro-QoL questionnaire
Keywords
stroke, dementia, Alzheimer disease, Health Brain, Health knowledge
Medical subject headings
Ischemic Stroke, Stroke, Dementia, Brain Ischemia, Brain Diseases, Alzheimer Disease, Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neuro-QoL questionnaireBehavioural

    Follow-up over time will continue (either in-person or over the phone) using the same questionnaires (depending on which group they are belongs to) at approximately 6-month intervals. During each follow-up, participants will be screened for any new signs, symptoms and diagnoses of neurological and/or psychiatric disorders, in order to correlate these outcomes with risk factors captured using the procedures described above.

Study groups in NCT03592563
Study groupRoleWhat they receive
Red groupThose participants who had established diagnosis of one or more neurological and/or psychiatric conditions Baseline: The participants' medical history, signs, symptoms and diagnoses of neurological and/or psychiatric disorders would be recorded. Neuro-QoL questionnaire plus an additional subset of questions based on their clinical diagnosis should be done.
Receives: Behavioral: Neuro-QoL questionnaire
Yellow groupThose participants who are high-risk to develop one or more neurological and/or psychiatric conditions, for example: 1. family history (first degree relative) one or more neurological and/or psychiatric conditions; 2. examination, imaging or laboratory findings consistent with pre-symptomatic stages of one or more neurological and/or psychiatric disorders. Baseline: The participants' medical history, signs, symptoms and diagnoses of neurological and/or psychiatric disorders would be recorded. Neuro-QoL questionnaire should be done.
Receives: Behavioral: Neuro-QoL questionnaire
Green groupThose participants who are not meeting criteria for Red or Yellow groups, but interested in longitudinal research on maintenance and/or improvement of their brain health. Baseline: The participants' medical history would be recorded and Neuro-QoL questionnaire should be done.
Receives: Behavioral: Neuro-QoL questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Risk factors contributing to neurological and psychiatric diseases

    The participants' electronic medical records and questionnaires done (either symptomatic or asymptomatic) would be compared with their follow-up electronic medical records/phone follow-up interview and questionnaires done over time.

    Measured: December, 2038

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2018
  2. Study start1 Jul 2019
  3. Primary completion31 Dec 2038 (estimated)
  4. Study completion31 Dec 2048 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
5,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03592563
Sponsor's protocol ID
Crec No. 2018.148
Acronym
BHS
Status last verified
Feb 2026
First submitted
13 Jun 2018
Last updated
24 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data and health information may be sent out to our research collaborators at Massachusetts General Hospital and Harvard Medical School, where there is a sister institute for brain health for additional analysis.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in